Instil Bio, Inc. (TIL)
Develops gene therapies to treat serious blood disorders and cancers.
$7.29+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-67.2%
The outlook
TIL is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages. Analyst coverage is modest, with an average price target about 4% below the current price. The overall sentiment leans bearish based on current market positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target -4% vs current price
Market cap
$49.4M
52-wk high
$33.83
52-wk low
$5.67
50-day avg
$7.77
200-day avg
$9.93
Trailing P/E
—